Barclays raised the firm’s price target on Alignment Healthcare (ALHC) to $18 from $13 and keeps an Equal Weight rating on the shares. The firm updated the company’s model following the earnings report.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALHC:
- Alignment Healthcare price target raised to $18 from $17 at UBS
- Alignment Healthcare Surpasses Q3 2025 Financial Expectations
- Alignment Healthcare: Strong Financial Performance and Strategic Growth Positioning Earns Buy Rating
- Alignment Healthcare reports Q3 EPS 2c, consensus (1c)
- Alignment Health Plan, Suvida Healthcare partner for bilingual care